Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4864)
All Articles published online
|
Publishing Process of This Article
|
Sep 27, 2018 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gigi E, Lagopoulos VI, Bekiari E. Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review. World J Hepatol 2018; 10(9): 595-602 [PMID: 30310537 DOI: 10.4254/wjh.v10.i9.595] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i9/595.htm |
| Number | Citing Articles |
| 1 |
Po-Yuan Ke. The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions. International Journal of Molecular Sciences 2018; 19(12): 3940 doi: 10.3390/ijms19123940
|
| 2 |
UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 2019; 7(S8): 189 doi: 10.1177/2050640619854671
|
| 3 |
Yusha Xiao, Baiyang Chen, Kang Yang, Quanxiong Wang, Pengpeng Liu, Yang Gu, Qiu Zhong, Zhisu Liu, Yueming He, Quanyan Liu. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Experimental Cell Research 2019; 383(2): 111542 doi: 10.1016/j.yexcr.2019.111542
|
| 4 |
Sara Kishta, Ashraf Tabll, Tea Omanovic Kolaric, Robert Smolic, Martina Smolic. Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals. Biomedicines 2020; 8(6): 175 doi: 10.3390/biomedicines8060175
|
| 5 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
|
| 6 |
Yuki Mori, Shuya Matsuda, Mitsuaki Sato, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Yasuhiro Nakayama, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment. Internal Medicine 2022; 61(18): 2721 doi: 10.2169/internalmedicine.8456-21
|
| 7 |
Patrick Huber, Robert Thimme. HCV-Therapie und Risiko für hepatozelluläres Karzinom bei Leberzirrhose. Gastro-News 2019; 6(6): 10 doi: 10.1007/s15036-019-0679-0
|
| 8 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
|
| 9 |
Dong Lin, Venu Reddy, Hanadi Osman, Adriana Lopez, Ali Riza Koksal, Sadeq Mutlab Rhadhi, Srikanta Dash, Yucel Aydin. Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells 2021; 10(4): 790 doi: 10.3390/cells10040790
|
| 10 |
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World Journal of Gastroenterology 2022; 28(1): 140-153 doi: 10.3748/wjg.v28.i1.140
|